{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:16Z","timestamp":1792801756302,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["82473434"],"award-info":[{"award-number":["82473434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFE0206600"],"award-info":[{"award-number":["2021YFE0206600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Science and Technology Cooperation Program of Chengdu Science and Technology Bureau","award":["2022-GH03-00004-HZ"],"award-info":[{"award-number":["2022-GH03-00004-HZ"]}],"id":[{"id":"https:\/\/ror.org\/00xfea068","id-type":"ROR","asserted-by":"crossref"}]},{"name":"International Science and Technology Cooperation Program of Chengdu Science and Technology Bureau","award":["2024-YF06-00011-HZ"],"award-info":[{"award-number":["2024-YF06-00011-HZ"]}],"id":[{"id":"https:\/\/ror.org\/00xfea068","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1245\/s10434-025-17600-6","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:13:50Z","timestamp":1749136430000},"page":"7059-7067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Patients with Bladder Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1245","volume":"32","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"6","key":"17600_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"17600_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev. 2023;20(5):287\u2013304. https:\/\/doi.org\/10.1038\/s41571-023-00744-3.","journal-title":"Nat Rev"},{"issue":"1","key":"17600_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, Zhai Z, Tanzhu G, Yang J, Zhou R. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9(1):170. https:\/\/doi.org\/10.1038\/s41392-024-01851-y.","journal-title":"Signal Transduct Target Ther"},{"key":"17600_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-981-99-3185-9_19","volume-title":"Cancer Stem Cells: Basic Concept and Therapeutic Implications","author":"K Soha","year":"2023","unstructured":"Soha K, Rahman MA, Islam F. Diagnostic and Prognostic Significance of Intracellular Markers of CSCs in Patients with Cancers. In: F Islam, AK Lam, editors. Cancer Stem Cells: Basic Concept and Therapeutic Implications. Singapore: Springer Nature Singapore; 2023. p. 349\u201372. https:\/\/doi.org\/10.1007\/978-981-99-3185-9_19."},{"issue":"3","key":"17600_CR5","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3390\/ijms24032400","volume":"24","author":"N Izycka","year":"2023","unstructured":"Izycka N, Rucinski M, Andrzejewska M, Szubert S, Nowak-Markwitz E, Sterzynska K. The prognostic value of cancer stem cell markers (CSCs) expression-ALDH1A1, CD133, CD44-for survival and long-term follow-up of ovarian cancer patients. Int J Mol Sci. 2023;24(3):2400. https:\/\/doi.org\/10.3390\/ijms24032400.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"17600_CR6","doi-asserted-by":"publisher","first-page":"13684","DOI":"10.1038\/s41598-021-93245-1","volume":"11","author":"M Blomqvist","year":"2021","unstructured":"Blomqvist M, Koskinen I, L\u00f6yttyniemi E, Mirtti T, Bostr\u00f6m PJ, Taimen P. Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer. Sci Rep. 2021;11(1):13684. https:\/\/doi.org\/10.1038\/s41598-021-93245-1.","journal-title":"Sci Rep"},{"issue":"3","key":"17600_CR7","doi-asserted-by":"publisher","first-page":"e24858","DOI":"10.1016\/j.heliyon.2024.e24858","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Yin Y, He Y, Meng F, Zhao J, Liu F, Xu Y, Wang G, Zhu X, Ma S, Lu H, Cai S, Song Y, Dai J. The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer. Heliyon. 2024;10(3):e24858. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24858.","journal-title":"Heliyon"},{"key":"17600_CR8","doi-asserted-by":"publisher","first-page":"115441","DOI":"10.1016\/j.bcp.2023.115441","volume":"209","author":"H Zhou","year":"2023","unstructured":"Zhou H, Tan L, Liu B, Guan XY. Cancer stem cells: recent insights and therapies. Biochem Pharmacol. 2023;209:115441. https:\/\/doi.org\/10.1016\/j.bcp.2023.115441.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"17600_CR9","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.juro.2010.01.064","volume":"183","author":"T Klatte","year":"2010","unstructured":"Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol. 2010;183(6):2403\u20138. https:\/\/doi.org\/10.1016\/j.juro.2010.01.064.","journal-title":"J Urol"},{"issue":"1","key":"17600_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","volume":"6","author":"HM Zhou","year":"2021","unstructured":"Zhou HM, Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6(1):62. https:\/\/doi.org\/10.1038\/s41392-020-00430-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"17600_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31(8):1101\u201312. https:\/\/doi.org\/10.1016\/j.stem.2024.06.003.","journal-title":"Cell Stem Cell"},{"key":"17600_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res ed). 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ (Clin Res ed.)"},{"issue":"1","key":"17600_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/21655979.2020.1765500","volume":"11","author":"Y Hu","year":"2020","unstructured":"Hu Y, Zhang YR, Gao JL, Lian X, Wang YT. The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered. 2020;11(1):572\u201381. https:\/\/doi.org\/10.1080\/21655979.2020.1765500.","journal-title":"Bioengineered"},{"issue":"3","key":"17600_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5507\/bp.2020.017","volume":"165","author":"J Hacek","year":"2021","unstructured":"Hacek J, Brisuda A, Babjuk M, Zamecnik J. Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165(3):316\u201321. https:\/\/doi.org\/10.5507\/bp.2020.017.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"2","key":"17600_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09674845.2019.1692761","volume":"77","author":"Z Siddiqui","year":"2020","unstructured":"Siddiqui Z, Srivastava AN, Sankhwar SN, Dalela D, Singh V, Zaidi N, Anjum S. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis. Br J Biomed Sci. 2020;77(2):69\u201375. https:\/\/doi.org\/10.1080\/09674845.2019.1692761.","journal-title":"Br J Biomed Sci"},{"issue":"5","key":"17600_CR16","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3892\/or.2016.5061","volume":"36","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi K, Matsumoto H, Matsuyama H, Fujii N, Inoue R, Yamamoto Y, Nagao K. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer. Oncol Rep. 2016;36(5):2852\u201360. https:\/\/doi.org\/10.3892\/or.2016.5061.","journal-title":"Oncol Rep"},{"issue":"12","key":"17600_CR17","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1245\/s10434-018-6706-0","volume":"25","author":"CT Wu","year":"2018","unstructured":"Wu CT, Lin WY, Chen WC, Chen MF. Predictive value of CD44 in muscle-invasive bladder cancer and its relationship with IL-6 signaling. Ann Surg Oncol. 2018;25(12):3518\u201326. https:\/\/doi.org\/10.1245\/s10434-018-6706-0.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"17600_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-014-1561-2","volume":"464","author":"BL Isfoss","year":"2014","unstructured":"Isfoss BL, Busch C, Hermelin H, Vermedal AT, Kile M, Braathen GJ, Berner A. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma. Virchows Arch. 2014;464(4):473\u201388. https:\/\/doi.org\/10.1007\/s00428-014-1561-2.","journal-title":"Virchows Arch"},{"issue":"2","key":"17600_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1158\/1055-9965.Epi-09-0865","volume":"19","author":"Y Su","year":"2010","unstructured":"Su Y, Qiu Q, Zhang XQ, Jiang ZR, Leng QX, Liu ZQ, Jiang F. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomark Prev. 2010;19(2):327\u201337. https:\/\/doi.org\/10.1158\/1055-9965.Epi-09-0865.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"17600_CR20","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.7314\/apjcp.2014.15.5.2013","volume":"15","author":"H Keymoosi","year":"2014","unstructured":"Keymoosi H, Gheytanchi E, Asgari M, Shariftabrizi A, Madjd Z. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev. 2014;15(5):2013\u201320. https:\/\/doi.org\/10.7314\/apjcp.2014.15.5.2013.","journal-title":"Asian Pac J Cancer Prev"},{"key":"17600_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12032-012-0445-z","volume":"30","author":"J Ruan","year":"2013","unstructured":"Ruan J, Wei B, Xu Z, Yang S, Zhou Y, Yu M, Liang J, Jin K, Huang X, Lu P, Cheng H. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer. Med Oncol. 2013;30:445. https:\/\/doi.org\/10.1007\/s12032-012-0445-z.","journal-title":"Med Oncol."},{"issue":"12","key":"17600_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.13240","volume":"11","author":"H Shen","year":"2015","unstructured":"Shen H, Blijlevens M, Yang N, Wilson KE, Xu B, Zhang Y, Zhang L, Morrison CD, Shepherd L, Hu Q, Zhu Q, Wang J, Liu S, Zhang J. Sox4 expression confers bladder cancer stem cell properties and predicts for poor patient outcome. Int J Biol Sci. 2015;11(12):1363\u201375. https:\/\/doi.org\/10.7150\/ijbs.13240.","journal-title":"Int J Biol Sci."},{"key":"17600_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/apm.12086","volume":"121","author":"AG Abdou","year":"2013","unstructured":"Abdou AG, Abd El-Wahed MM, Kandil MA, Samaka RM, Elkady N. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma. APMIS. 2013;121:982\u201396. https:\/\/doi.org\/10.1111\/apm.12086.","journal-title":"APMIS."},{"issue":"6","key":"17600_CR24","first-page":"1154","volume":"15","author":"N Hatefi","year":"2012","unstructured":"Hatefi N, Nouraee N, Parvin M, Ziaee SJM, Mowla SJ. Evaluating the expression of Oct4 as a prognostic tumor marker in bladder cancer. Iran J Basic Med Sci. 2012;15(6):1154\u201361.","journal-title":"Iran J Basic Med Sci."},{"issue":"5","key":"17600_CR25","doi-asserted-by":"publisher","first-page":"e0269214","DOI":"10.1371\/journal.pone.0269214","volume":"18","author":"A Hamid","year":"2023","unstructured":"Hamid A, Syadza YZ, Yausep OE, Christanto RBI, Muharia BHR, Mochtar CA. The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: a systematic review. PLOS One. 2023;18(5):e0269214. https:\/\/doi.org\/10.1371\/journal.pone.0269214.","journal-title":"PLOS One"},{"issue":"1","key":"17600_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5115\/acb.2014.47.1.1","volume":"47","author":"S Amini","year":"2014","unstructured":"Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014;47(1):1\u201311. https:\/\/doi.org\/10.5115\/acb.2014.47.1.1.","journal-title":"Anat Cell Biol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17600-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:01:53Z","timestamp":1754150513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17600-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["17600"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17600-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have applied and confirm that there are no conflicts of interest regarding the publication of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}